AFJKU
AFJKU
Aimei Health Technology Co., Ltd UnitIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $130.15K ▲ | $352.02K ▼ | 0% | $0.06 ▼ | $-130.15K ▼ |
| Q2-2025 | $0 | $41.6K ▼ | $424.97K ▲ | 0% | $0.07 ▲ | $-41.6K ▼ |
| Q1-2025 | $0 | $413.41K ▲ | $184.66K ▼ | 0% | $0.02 ▼ | $184.66K ▼ |
| Q4-2024 | $0 | $402.02K ▲ | $444.11K ▼ | 0% | $0.05 ▼ | $444.11K ▼ |
| Q3-2024 | $0 | $200.02K | $743.51K | 0% | $0.08 | $743.51K |
What's going well?
The company is earning a significant amount of interest income ($482,171), which is keeping it profitable on paper. The drop in share count boosts earnings per share for remaining shareholders.
What's concerning?
There is no revenue and operating losses are rising fast, from $41,604 to $130,152. All profits come from interest income, not from running a business, which is not sustainable.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $2.98K ▲ | $45.47M ▲ | $3.46M ▲ | $42M ▲ |
| Q2-2025 | $2.14K ▼ | $44.56M ▲ | $2.9M ▲ | $41.65M ▲ |
| Q1-2025 | $7.34K ▼ | $43.6M ▼ | $2.38M ▲ | $41.23M ▼ |
| Q4-2024 | $28.21K ▼ | $73.81M ▲ | $1.51M ▲ | $72.31M ▲ |
| Q3-2024 | $103.56K | $72.78M | $920.79K | $71.86M |
What's financially strong about this company?
The company is mostly funded by shareholders, with very little debt and no risky goodwill or intangibles. Its asset base is solid, and equity increased this quarter.
What are the financial risks or weaknesses?
Liquidity is in crisis: the company has almost no cash and can't cover its short-term bills with current assets. Retained losses are growing, and payables are rising.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $352.02K ▼ | $-96.11K ▲ | $-450K | $546.95K ▼ | $841 ▲ | $-96.11K ▲ |
| Q2-2025 | $424.97K ▲ | $-201.75K ▲ | $-450K ▼ | $646.54K ▲ | $-5.21K ▲ | $-201.75K ▲ |
| Q1-2025 | $184.66K ▼ | $-224.01K ▼ | $30.79M ▲ | $-30.58M ▼ | $-20.86K ▲ | $-224.01K ▼ |
| Q4-2024 | $444.11K ▼ | $-195.13K ▼ | $-277.7K ▼ | $397.48K ▲ | $-75.35K ▼ | $-195.13K ▼ |
| Q3-2024 | $743.51K | $-53.95K | $0 | $0 | $-53.95K | $-53.95K |
What's strong about this company's cash flow?
Cash burn is shrinking quarter over quarter, and working capital changes helped cash flow this time. The company is not diluting shareholders with new stock.
What are the cash flow concerns?
Operations are still losing real cash, and the business cannot survive without new debt. The cash balance is critically low, and the quality of earnings is poor.
5-Year Trend Analysis
A comprehensive look at Aimei Health Technology Co., Ltd Unit's financial evolution and strategic trajectory over the past five years.
AFJKU benefits from a growing asset and equity base, strong reported net income driven by interest income, and demonstrated access to capital through equity and debt financing. Its planned merger offers exposure to a structurally growing theme in hydrogen and green energy, where the target business aims to cover the full value chain and assist customers with decarbonization. For now, the balance sheet is not highly leveraged in the long term, and the SPAC structure provides a ready-made listing platform for the combined entity.
Key risks include the complete absence of operating revenue, widening operating losses, and negative operating and free cash flow, which together show that there is not yet a self‑funding business. Liquidity has deteriorated sharply, with much lower cash and much higher short-term obligations, increasing refinancing and funding risk. Retained losses are deepening, and the company is increasingly reliant on financial income and external capital. On top of this, the entire forward story depends on the successful and timely completion of the merger and on United Hydrogen’s ability to compete and execute in a highly uncertain and capital‑intensive sector.
AFJKU’s near‑term outlook is dominated by transaction and liquidity milestones rather than by organic business trends. In the short run, maintaining adequate cash, managing short-term debt, and progressing the merger will likely be the central focus. Looking further ahead, if the merger is completed and United Hydrogen can turn its integrated hydrogen strategy into profitable, cash‑generating operations, AFJKU’s current financial profile could change dramatically. Until that happens, the outlook remains highly conditional, with meaningful upside potential tied to the energy transition but also substantial execution, funding, and competitive risks.
About Aimei Health Technology Co., Ltd Unit
Aimei Health Technology Co Ltd is a blank check company.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $130.15K ▲ | $352.02K ▼ | 0% | $0.06 ▼ | $-130.15K ▼ |
| Q2-2025 | $0 | $41.6K ▼ | $424.97K ▲ | 0% | $0.07 ▲ | $-41.6K ▼ |
| Q1-2025 | $0 | $413.41K ▲ | $184.66K ▼ | 0% | $0.02 ▼ | $184.66K ▼ |
| Q4-2024 | $0 | $402.02K ▲ | $444.11K ▼ | 0% | $0.05 ▼ | $444.11K ▼ |
| Q3-2024 | $0 | $200.02K | $743.51K | 0% | $0.08 | $743.51K |
What's going well?
The company is earning a significant amount of interest income ($482,171), which is keeping it profitable on paper. The drop in share count boosts earnings per share for remaining shareholders.
What's concerning?
There is no revenue and operating losses are rising fast, from $41,604 to $130,152. All profits come from interest income, not from running a business, which is not sustainable.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $2.98K ▲ | $45.47M ▲ | $3.46M ▲ | $42M ▲ |
| Q2-2025 | $2.14K ▼ | $44.56M ▲ | $2.9M ▲ | $41.65M ▲ |
| Q1-2025 | $7.34K ▼ | $43.6M ▼ | $2.38M ▲ | $41.23M ▼ |
| Q4-2024 | $28.21K ▼ | $73.81M ▲ | $1.51M ▲ | $72.31M ▲ |
| Q3-2024 | $103.56K | $72.78M | $920.79K | $71.86M |
What's financially strong about this company?
The company is mostly funded by shareholders, with very little debt and no risky goodwill or intangibles. Its asset base is solid, and equity increased this quarter.
What are the financial risks or weaknesses?
Liquidity is in crisis: the company has almost no cash and can't cover its short-term bills with current assets. Retained losses are growing, and payables are rising.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $352.02K ▼ | $-96.11K ▲ | $-450K | $546.95K ▼ | $841 ▲ | $-96.11K ▲ |
| Q2-2025 | $424.97K ▲ | $-201.75K ▲ | $-450K ▼ | $646.54K ▲ | $-5.21K ▲ | $-201.75K ▲ |
| Q1-2025 | $184.66K ▼ | $-224.01K ▼ | $30.79M ▲ | $-30.58M ▼ | $-20.86K ▲ | $-224.01K ▼ |
| Q4-2024 | $444.11K ▼ | $-195.13K ▼ | $-277.7K ▼ | $397.48K ▲ | $-75.35K ▼ | $-195.13K ▼ |
| Q3-2024 | $743.51K | $-53.95K | $0 | $0 | $-53.95K | $-53.95K |
What's strong about this company's cash flow?
Cash burn is shrinking quarter over quarter, and working capital changes helped cash flow this time. The company is not diluting shareholders with new stock.
What are the cash flow concerns?
Operations are still losing real cash, and the business cannot survive without new debt. The cash balance is critically low, and the quality of earnings is poor.
5-Year Trend Analysis
A comprehensive look at Aimei Health Technology Co., Ltd Unit's financial evolution and strategic trajectory over the past five years.
AFJKU benefits from a growing asset and equity base, strong reported net income driven by interest income, and demonstrated access to capital through equity and debt financing. Its planned merger offers exposure to a structurally growing theme in hydrogen and green energy, where the target business aims to cover the full value chain and assist customers with decarbonization. For now, the balance sheet is not highly leveraged in the long term, and the SPAC structure provides a ready-made listing platform for the combined entity.
Key risks include the complete absence of operating revenue, widening operating losses, and negative operating and free cash flow, which together show that there is not yet a self‑funding business. Liquidity has deteriorated sharply, with much lower cash and much higher short-term obligations, increasing refinancing and funding risk. Retained losses are deepening, and the company is increasingly reliant on financial income and external capital. On top of this, the entire forward story depends on the successful and timely completion of the merger and on United Hydrogen’s ability to compete and execute in a highly uncertain and capital‑intensive sector.
AFJKU’s near‑term outlook is dominated by transaction and liquidity milestones rather than by organic business trends. In the short run, maintaining adequate cash, managing short-term debt, and progressing the merger will likely be the central focus. Looking further ahead, if the merger is completed and United Hydrogen can turn its integrated hydrogen strategy into profitable, cash‑generating operations, AFJKU’s current financial profile could change dramatically. Until that happens, the outlook remains highly conditional, with meaningful upside potential tied to the energy transition but also substantial execution, funding, and competitive risks.

CEO
Junheng Xie
Compensation Summary
(Year )
Ratings Snapshot
Rating : C-

